loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 209422 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Dr. Reddy's Laboratories

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    Key Products KEY PRODUCTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 DR REDDYS (1)

    filter

    01 POWDER;INTRAVENOUS (1)

    filter

    01 RX (1)

    filter

    01 CARFILZOMIB (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CARFILZOMIB

    PDF Supplier PDF
    URL Supplier Web Content
    POWDER; INTRAVENOU...
    60MG/VIAL
    2019-09-09
    209422
    CARFILZOMIB
    RX
    No
    AP
    Dr Reddy Company Banner

    CPhI North America

    Attending

    envelop Contact Supplier

    Looking for FDA Orange Book APPLICATION 209422

    Looking for FDA Orange Book APPLICATION 209422 1

    19

    Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    One of their notable products is CARFILZOMIB, with a corresponding application number 209422.

    Regulatory Information RX

    With a dosage strength 60MG/VIAL

    Dosage Form Route POWDER; INTRAVENOUS

    Reference Listed Drug No

    Approved since 2019-09-09

    Therapeutic Equivalence (TE) Code AP

    Post Enquiry
    POST ENQUIRY